Removal of Pu and am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S). 1984

R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones

Decorporation of Pu and Am by tetrameric catechoylamide (CAM) ligands has been investigated in beagles and mice. Eight dogs were injected intravenously (iv) with 237 + 239Pu(IV) + 241Am(III) citrate, and 30 min later, pairs of dogs were injected iv with 30 mumole/kg of 3,4,3-LICAM(C) [N1,N5,N10,N14-tetrakis(2,3-dihydroxy-5-sulfobenzoyl)tetr aazatetradecane, tetrasodium salt], 3,4,3-LICAM(S) [N1,N5,N10,N14-tetrakis(2,3-dihydroxy-4-carboxybenzoyl)te traazatetradecane, tetrasodium salt], CaNa3-DTPA, or each of the latter two ligands. Blood was sampled, and excreta were collected for 7 days, at which time the dogs were sacrificed and nuclide retention in liver and nonliver tissue was measured. Groups of five mice were each given 238Pu(IV) or 241Am(III) citrate iv; 3 min later 30 mumole/kg of a CAM ligand was injected intraperitoneally, mice were killed at 24 hr, and separated excreta and tissues were analyzed. In the dogs, average retention at 7 days of the injected Pu and Am, respectively, was as follows: 12 and 70% after treatment with a CAM ligand alone; 30 and 20% after DTPA; 12 and 20% after LICAM(S) plus DTPA; 90 and 89% without a ligand. In the mice, mean retention of the injected Pu and Am, respectively, was as follows: 14 and 66% after treatment with LICAM(C); 21 and 54% after LICAM(S); 91 and 87% without a ligand. In both species, about 99% of net Pu excretion (excretion with ligand - excretion without ligand) promoted in 24 hr by DTPA or LICAM(S) was in the urine, whereas about 10% of net Pu excretion promoted by the less hydrophilic LICAM(C) was in feces. Delayed excretion of both Am and Pu was significant in all ligand-treated dogs. Comparison of the nuclide content of tissues of ligand-treated mice with those of mice killed 3 min after nuclide injection indicated that the CAM ligands chelated circulating Pu and Am and prevented further deposition. In addition, the CAM ligands removed much of the presumably loosely bound Pu present in liver and skeleton at the time of ligand injection. LICAM(C) was more effective in removing Pu from liver and LICAM(S) was more effective in the skeleton. Moderate to severe uremia and histological evidence of cell killing in the distal tubules of the kidney were observed in the four dogs injected once with 30 mumole/kg of LICAM(S).(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D011005 Plutonium A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D003666 Decontamination The removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000576 Americium A completely man-made radioactive actinide with atomic symbol Am, and atomic number 95. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
January 1986, Radiation and environmental biophysics,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
March 1985, Radiation research,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
June 1989, Health physics,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
September 1986, Human toxicology,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
January 2003, Radiation protection dosimetry,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
September 1979, Radiation research,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
November 1972, Health physics,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
April 2006, Physical review letters,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
December 1996, International journal of radiation biology,
R D Lloyd, and F W Bruenger, and C W Mays, and D R Atherton, and C W Jones, and G N Taylor, and W Stevens, and P W Durbin, and N Jeung, and E S Jones
June 1993, International journal of radiation biology,
Copied contents to your clipboard!